Permeability of frog skin to chemicals: effect of penetration enhancers by Llewelyn, Victoria K. et al.
Heliyon 5 (2019) e02127Contents lists available at ScienceDirect
Heliyon
journal homepage: www.heliyon.comPermeability of frog skin to chemicals: effect of penetration enhancers
Victoria K. Llewelyn a,*, Lee Berger b, Beverley D. Glass a
a Pharmacy, College of Medicine and Dentistry, James Cook University, Townsville, 4811, Australia
b One Health Research Group, Melbourne Veterinary School, University of Melbourne, Werribee, 3029, AustraliaA R T I C L E I N F O
Keywords:
Pharmaceutical science
Toxicology
Zoology* Corresponding author.
E-mail address: victoria.llewelyn@my.jcu.edu.au
https://doi.org/10.1016/j.heliyon.2019.e02127
Received 2 April 2019; Received in revised form 2
2405-8440/© 2019 The Authors. Published by Else
nc-nd/4.0/).A B S T R A C T
Rarely do commercial chemical products contain solely the active chemical/ingredient. It is therefore important
to consider whether ingredients other than the active may: 1) alter absorption of the active chemical, or 2) be
absorbed themselves, resulting in systemic effects. Frogs have highly permeable skin and are routinely exposed to
commercial chemical products in the environment or therapeutically. Ethanol and propylene glycol (PG), which
have known penetration-enhancing effects, are commonly included in such products. The current study has
therefore investigated the in vitro absorption kinetics through Rh. marina skin of three model chemicals – caffeine,
benzoic acid, and ibuprofen – formulated individually as solutions containing: 1%, 10% or 30% v/v ethanol, or
20% v/v PG. Differential scanning calorimetry and histology were used to characterise fresh frog skin, investigate
the mechanism of these enhancers in frog skin, and to determine whether these enhancers significantly affected
skin structure. Results showed that the extent of absorption enhancement was influenced by chemical, enhancer
and skin region, and that enhancement was generally not consistent for individual enhancers or skin regions. The
exception was 1% v/v ethanol, which did not significantly alter flux across the skin for any of the chemicals
evaluated. Caffeine absorption was not enhanced by any of the investigated penetration enhancers, and was in
fact significantly reduced by 30% v/v ethanol and PG. Ethanol caused concentration-dependant changes in skin
morphology and should be avoided in concentrations 10% v/v. PG, however, caused minimal changes to the
skin and consistently improved absorption of benzoic acid and ibuprofen through all skin regions. Owing to the
significant changes in skin structure following 10% v/v ethanol exposure, it is recommended to avoid its use in
frogs. For enhancement of penetration of moderately-to-highly lipophilic chemicals, this study has identified 20%
v/v PG should to be the enhancer of choice.1. Introduction
Penetration enhancers, substances that can partition into the skin and
increase the absorption of chemicals, are commonly included in agri-
cultural, industrial and therapeutic formulations. There is substantial
evidence that these substances are able to significantly reduce the barrier
function of the mammalian epidermis, resulting in greater systemic
exposure to topically-administered chemicals. However, despite the
common inclusion of penetration enhancers in formulations, their impact
on absorption in most non-mammalian species remains unknown.
Frog skin is highly-permeable and structurally different from
mammalian skin, owing to the role of frog skin in maintaining physio-
logical homeostasis (fluid, electrolyte and acid/base balance). The stra-
tum corneum (SC), accepted as the primary barrier to percutaneous
absorption in mammals, is much thinner in frogs. While in mammals the
SC is often 10–20 cell layers thick, in frogs it commonly consists of only(V.K. Llewelyn).
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vier Ltd. This is an open access arone or two cell layers [1]. Thus, it is unsurprising that the limited
comparative studies of chemical absorption in frog and mammalian skins
have reported much higher absorption in frog skin [2, 3]. As absorption
rates are already heightened in frogs compared to in mammals, it is likely
that inclusion of a penetration enhancer in a chemical formulation will
also have a heightened effect in frog skin.
Frogs are experiencing significant population declines and extinctions
worldwide. While much of the decline has been attributed to disease,
especially infectious chytridiomycosis, habitat change and contamina-
tion have also been identified as causative factors [4]. The dynamic
interaction between frogs' skin and the immediate environment is the
reason for their heightened sensitivity to environmental contaminants,
and this heightened sensitivity has, in turn, led to frogs being considered
indicators of the relative health of an ecosystem. They therefore repre-
sent an ideal non-mammalian candidate in which to investigate the
impact of penetration enhancers on percutaneous absorption, as they are19
ticle under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-
Table 1
LogP of each model chemical, and the composition, saturation solubility data and
sampling times for each donor solution used in the absorption kinetics/diffusion
cell experiments *values from [17].
Model
drug
LogP Donor solution
composition (% v/v)
Saturated
solubility (g/
L)
Sampling
times (hr)
ARS Ethanol PG
Benzoic
acid
1.87 100% – – 3.972* 0, 0.5, 1, 1.5,
2, 2.5, 3, 4, 5,
6
Benzoic
acid
99% 1% – 5.240 0, 0.5, 1, 1.5,
2, 2.5, 3, 4, 5
Benzoic
acid
70% 30% – 12.101 0, 0.5, 1, 1.5,
2, 2.5, 3, 4, 5
Benzoic
acid
80% – 20% 2.619 0, 0.5, 1, 1.5,
2, 2.5, 3, 4, 5
Caffeine -0.07 100% – – 20.298* 0, 0.5, 1, 1.5,
2, 2.5, 3, 4, 5,
6
Caffeine 99% 1% – 19.238 0, 0.5, 1, 1.5,
2, 2.5, 3, 4
Caffeine 70% 30% – 20.046 0, 0.5, 1, 1.5,
2, 2.5, 3, 4, 5
Caffeine 80% – 20% 17.947 0, 0.5, 1, 1.5,
2, 2.5, 3, 4, 5
Ibuprofen 3.97 100% – – 0.490* 0, 0.5, 1, 1.5,
2, 2.5, 3, 4, 5,
6
Ibuprofen 99% 1% – 0.243 0, 0.5, 1, 1.5,
2, 2.5, 3, 4, 5,
6
Ibuprofen 90% 10% – 0.810 0, 0.5, 1, 1.5,
2, 2.5, 3, 4, 5
Ibuprofen 70% 30% – 1.338 0, 0.5, 1, 1.5,
2, 2.5, 3, 4, 5,
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disease and in also in the wild.
A variety of ingredients with potential penetration-enhancing effects
are regularly included in commercially-available products, particularly
as co-solvents (to assist in the dissolution of the active chemical). In
therapeutic drug products, the most common co-solvent used is ethanol,
although propylene glycol (PG), owing to its relatively lower toxicity in
vivo, is also widely included, particularly in topical and cosmetic for-
mulations [5]. Further, as commercially-available drug products are
often inappropriate for administration directly to exotic species including
frogs, clinicians are often required to compound their own formulations.
Owing to their availability and favourable solubility profiles, ethanol and
PG also represent the most-commonly used solvents used when com-
pounding drug products for topical application. Ethanol also finds
extensive use in agricultural and industrial formulations. In particular,
the identification of ethanol as a “green” solvent has increased its use in
manufacturing, inclusion in fuels, and as a solvent in agrichemicals [6].
PG is most commonly included in antifreeze for aircraft, and so can easily
contaminate surrounding environments when in use [7]. While neither
PG nor ethanol persist in the environment, acute impacts on wildlife
when products containing these ingredients are introduced into the
environment cannot be ignored.
Penetration enhancers may influence absorption by allowing higher
concentrations of active chemical to be dissolved in the formulation it-
self, and also by altering the barrier properties of the skin – usually by
inducing changes in the lipoid structure/packing of the epidermal layer.
Almost all penetration enhancers act via more than one mechanism, and
sometimes the primary mechanism of enhancement changes, depending
on the concentration of enhancer used. Ethanol is postulated to improve
absorption by: increasing chemical solubility in formulation, diffusing
itself into the SC thereby improving solubility of the active chemical in
the SC, and having a multitude of effects on intradermal lipids, causing
lipid fluidisation, restructuring of the lipids, and at high concentrations,
lipid extraction from the SC [8]. The mechanism of PG in improving
percutaneous absorption is similarly debated; its effects have been
attributed to: diffusion into the SC, improving solubility of the active
chemical in the SC, interaction with the polar headgroups of the lipid
bilayers of the skin altering the lipid packing, and alteration of protein
composition in the skin [9, 10]. In order to elucidate the underlying
mechanism of penetration enhancers, studies often consider the results of
in vitro absorption studies alongside investigations of changes in the skin
structure following exposure to the penetration enhancers. Various
techniques have been used to study the effect of penetration enhancers
on skin structure, including light, electron and confocal microscopy,
Raman and Fourier transform infrared spectroscopy, differential scan-
ning calorimetry (DSC) and X-ray diffractometry [11].
As penetration enhancers have different effects depending on the
characteristics of the skin to which they are applied and the formulation
in which they are included, it is difficult to consistently predict the
impact an enhancer will have on skin structure and function. As frog skin
is structurally different from mammalian skin, and penetration-
enhancers likely to be included in therapeutic formulations used in
frogs, and also present in frog habitats, studies are needed to investigate
their effect on chemical absorption through frog skin. Further, given the
vital role of frog skin in maintaining physiological homeostasis, it is also
important to ensure that the integrity of the skin is not significantly
altered following application of penetration enhancers.
The current study investigated the effect of the addition of ethanol or
PG to an aqueous formulation containing one of three model chemicals
on the absorption kinetics through frog skin. In order to further under-
stand the underlying mechanism of penetration enhancement in frog
skin, DSC and histology were used to characterise frog skin, prior to and
after exposure to these penetration enhancers.22. Material and methods
2.1. Chemicals and solutions
Model chemicals used were reagent grade caffeine, ACS reagent grade
benzoic acid (both Sigma-Aldrich) and 98% ibuprofen (Sigma).
Amphibian Ringer's solution (ARS), used in both donor and receptor
solutions, was prepared according to Wright and Whitaker [12] con-
taining: 113 mM sodium chloride, 2 mM potassium chloride, 1.35 mM
calcium chloride, and 2.4 mM sodium bicarbonate. For all ibuprofen
experiments, ARS was spiked with 2-hydroxypropyl-beta-cyclodextrin
(HPβCD; Aldrich Chemistry) 2.75 mg/ml to ensure adequate solubiliza-
tion. Donor solutions (Table 1) comprised a saturated (“infinite dose”)
solution of each of the model chemicals in either: (a) 1% v/v ethanol, (b)
10% v/v ethanol (ibuprofen only), (c) 30% v/v ethanol, or (d) 20% v/v
PG, all prepared in ARS  HPβCD. As the study included prolonged
exposure, the penetration enhancers chosen, and concentrations used,
were selected due to their inclusion in commercially-available drug
products, at amounts reported to be safe in frogs. 10% v/v ethanol was
included as a mid-range concentration in the ibuprofen studies, after
preliminary studies showed almost no influence of 1% v/v ethanol and
extremely high absorption from 30% v/v ethanol. To ensure solubilisa-
tion of the chemicals in the receptor solution, all receptor solutions
comprised ARS spiked with 2-hydroxypropyl-beta-cyclodextrin (HPβCD;
Aldrich Chemistry): 2.75 mg/ml HPβCD was used for the caffeine and
ibuprofen experiments, and 5.75 mg/ml HPβCD for benzoic acid exper-
iments. Euthanasia of animals was carried out by bathing in a solution of
0.2% w/v ethyl 3-aminobenzoate methanesulfonate solution (MS-222;
Aldrich Chemistry), buffered to pH 7.3 with sodium bicarbonate.
Methanol and acetonitrile used were high-performance liquid chro-
matography (HPLC) grade (Fisher Chemicals, Trinidad and Thermo6
Ibuprofen 80% – 20% 0.262 0, 0.5, 1, 1.5,
2, 2.5, 3, 4
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Fisher Scientific, Australia) and water used for HPLC was ultrapure
(Milli-Q Integral, Millipore Australia). All solutions were freshly
prepared.
2.1.1. Determining saturation solubility of donor solutions
The saturation solubility of each chemical in each penetration
enhancer solution was determined by placing an excess of chemical into
5–100 mL of penetration enhancer solution. The resultant mixture was
then sonicated at room temperature for 24 hr before centrifuging at
12,000 RCF for 15 minutes. Supernatant was removed, diluted appro-
priately with ARS þ HPβCD, and analysed using previously-validated
HPLC methods [13].
2.2. Study animals
Adult male Rhinella marina (cane toads), wild-caught in the Towns-
ville region (Australia) were used in this study. The cane toad has a wide
distribution, being a native species in Central and South America, and
also having been introduced several nations in the Asia-Pacific region
[14]. Extensive biological and ecological research exists for this species,
including baseline kinetics of skin absorption. Cane toads are also
generally not adversely affected by chytridiomycosis infection (only
metamorphs and subadults succumb to the disease [15]), and so present a
suitable model for design and trial of therapeutic treatments for this
infection. This species, therefore, represents an appropriate model spe-
cies when investigating the impact of penetration enhancers on the skin
of frogs. Thirty-four toads, ranging from 54.5 – 128.65 g body weight
(mean ¼ 89.74 g) were randomly allocated to one of the penetration
enhancer/chemical treatments. Twenty-five toads were used for the in
vitro penetration enhancer experiments, and the remaining toads pro-
vided skin samples both for histological analysis (light microscopy) and
DSC experiments. Toads were handled carefully in order to minimize
potential damage to the skin. Euthanasia was carried out within 24 hr of
collection. Full-thickness skin samples were excised immediately after
euthanasia. For all studies, each toad provided five skin samples from a
combination of the following skin regions: dorsal bilaterally from the
central dorsal truncal midline, ventral pelvic bilaterally along the pelvic
truncal midline, ventral thoracic bilaterally from the central ventral
truncal midline. All studies were completed in accordance with Animal
Ethics approval A2222 from James Cook University, Australia.
2.3. Diffusion cell experiments
The effect of penetration enhancers on the absorption of model
chemicals in static Franz diffusion cells (Permegear, USA) was investi-
gated. Each diffusion cell consisted of a 1 ml donor chamber with a 9 mm
orifice, and a 5 ml receptor chamber. The donor chamber was filled with
a saturated solution of one of the model chemicals (benzoic acid,
caffeine, or ibuprofen) in ARS ( HPβCD) þ penetration enhancer, as
outlined in section 2.1. Receptor solution (ARS þ HPβCD) was magnet-
ically stirred and allowed to equilibrate in the diffusion cell for 30 mi-
nutes prior to skin mounting. Prior to mounting, each skin sample was
rinsed in ARS andmicroscopically inspected for signs of damage. Samples
were mounted on diffusion cells with the external skin surface facing the
donor chamber. Samples with signs of damage were not used in the
study.
After mounting skin samples on the diffusion cell, 1 ml of donor so-
lution was applied to the donor chamber, and the chamber was occluded
by application of laboratory film (Parafilm M™, Pecheney Plastics
Packaging, Chicago) to the external donor chamber orifice. 1 ml samples
were then collected from the receptor chamber until steady-state was
achieved for at least four sampling points, as indicated in preliminary
studies (data not included). Samples were collected from the center of the
diffusion cell, by inserting a 200mm long stainless-steel needle via the3sidearm and withdrawing the sample from directly above the stir bar into
a glass syringe. Samples were collected at t¼ 0, 0.5, 1, 1.5, 2, 2.5, 3 and 4
hr for caffeine in 1% v/v ethanol. All other caffeine experiments followed
the same schedule with an additional sample taken at t ¼ 5 hr. All ben-
zoic acid samples were taken at t ¼ 0, 0.5, 1, 1.5, 2, 3, 4 and 5 hr.
Ibuprofen samples were withdrawn at t ¼ 0, 0.5, 1, 1.5, 2, 3, and 4 hr
when dissolved in 20% v/v PG, with an additional sample withdrawn at t
¼ 5 hr for the 10% v/v ethanol-containing samples, and two additional
samples (t ¼ 5 and t ¼ 6 hr) for ibuprofen in 1% v/v or 30% v/v ethanol
(Table 1). Immediately following sample collection, fresh receptor so-
lution was added to the receptor chamber using a clean needle and glass
syringe, the chamber inverted to ensure no air bubbles were present, and
the chamber then returned to its holder. This allowed replenishment of
lost receptor chamber volume from sample collection, while also
ensuring that fresh receptor solution was mixed into the remaining donor
chamber solution. Collected samples were analyzed for the chemical
content using previously-described HPLC methods [13].
2.3.1. High-performance liquid chromatography (HPLC)
The HPLC system comprised a Shimadzu Nexera-i LC-2040C 3D
equipped with a photodiode-array detector. Post-run analysis was per-
formed using Labsolutions 5.82 (Shimadzu). All HPLC methods have
been validated and previously described [13]. As the penetration en-
hancers used in this study could potentially interfere with the analysis,
specificity was investigated. Blank samples containing 100% penetration
enhancer, samples of individual penetration enhancers spiked with
known quantities of each of the chemicals, and samples run in unspiked
ARS were injected onto the column to ensure no interference with the
chemical peak occurred. All methods remained specific for the determi-
nation of the respective chemicals and no interference was detected, thus
specificity was assured. HPLC methods were therefore used as previously
reported. Calibrations were performed daily (r2> 0.999), and all samples
measured in triplicate.
2.3.2. Data analysis and statistics
Data were examined and analyzed using R [16]. Previously-collected
data involving percutaneous absorption of model chemicals from ARS
[17] were included in data analyses to determine any differences in ab-
sorption due to the penetration enhancers.
Cumulative absorption versus time plots were produced for each
sample, and any curves with significant deviation suggestive of skin
damage were excluded. Consequently, results from four samples were
excluded from further analysis.
Flux (mcg/cm2/hr; Jss) was determined for each sample from the
steady-state slope of the cumulative absorption versus time plot. Steady
state was identified as the slope taken from at least four consecutive
sampling points, after initial equilibration had occurred. In the case of
30% ethanol, where a distinct lag phase was noted, we ensured that the
first sampling timepoint for calculation of the linear portion of the curve
was no less than 2.3 x lag time (as per [18]). Permeability coefficient (Kp)
was calculated by dividing flux by the concentration of chemical in the
donor solution (Kp ¼ Jss/Cv). Concentration of drug in the donor solution
(Cv) was the saturation solubility of each chemical in the penetration
enhancer as determined in stage 1 of this study (sections 2.1.1 and 3.1;
Table 1). In addition to data collected in this study, Kp was calculated
from previously-collected data involving percutaneous absorption of the
model chemicals from ARS [17].
The effect of the penetration enhancer and skin region on chemical
flux through the skin was determined for each individual chemical by
fitting a series of linear mixed-effects models using the nlme package
[19]. Each model used penetration enhancer as the fixed factor, included
the individual animal as a random effect, and allowed for hetero-
skedasticity in the data.
Enhancement ratio (ER) was calculated for each drug/penetration
enhancer formulation, as the ratio of Kp of each drug in penetration
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comparison of relative effect of each penetration enhancer to each other
and ARS, for a specific skin region and model chemical. ERs reported are
the mean ratios from at least four replicates.
2.4. Differential scanning calorimetry (DSC)
The thermal behavior of dorsal and ventral frog skin was investigated
using differential scanning calorimetry (DSC; Mettler Toledo DSC822e
with STARe version 14.00). Full-thickness skin samples were used in the
study, either freshly-excised or skin that had been exposed to ARS or
penetration enhancer solutions for 6 hr. Skin was prepared and mounted
on diffusion cells as described in sections 2.2 and 2.4. Donor solutions
were as outlined in section 2.1, however model chemicals were not
included in any solutions. The donor solutions thus comprised of: (a)
ARS, (b) 1% v/v ethanol, (c) 10% v/v ethanol, (d) 30% v/v ethanol, or (e)
20% v/v PG, all prepared in ARS. The receptor solution for all studies was
ARS to maintain viability of the inner skin surface. Following the 6-hr
exposure time, skin samples were removed from the diffusion cells,
rinsed with ARS, and blot-dried. Exposed skin was then excised from
surrounding (non-exposed) tissue, cut into pieces weighing approxi-
mately 20 mg, and sealed in 40 mcl aluminium crucibles. Baseline
samples of freshly-excised frog skin were used in the investigation of the
ramp rate on DSC output. Heating rates of 1 C, 5 C and 10 C/min were
investigated, with optimal balance between resolution, sensitivity, and
reproducibility seen with the 5 C/min heating rate. Thus, all samples
were analysed over the temperature range 30–150 C, with a heating rate
of 5 C/min under nitrogen flow. Transition data represent the average of
at least three skin samples.
2.5. Histology
Ventral and dorsal skin samples, either fresh or following exposure to
ARS or penetration enhancers as part of the DSC experiments, were
preserved in 4% phosphate-buffered formaldehyde. Preserved skin was
then dehydrated and processed for histology using standard methods to
produce 5 mcm sections on slides stained with haematoxylin and eosin.
3. Results
3.1. Saturation solubility studies
Table 1 presents the solubility data for each chemical in each of the
penetration enhancer solutions. Increasing concentrations of ethanol
increased the solubility of both benzoic acid and ibuprofen, with solu-
bility increasing 3-fold for benzoic acid in 30% v/v ethanol, and 2-foldFig. 1. Cumulative absorption versus time curves for absorption of caffeine for the v
Rh. marina skin. Error bars show standard error. ARS data from [17].
4for ibuprofen. 20% v/v PG decreased the solubility of all chemicals
investigated (Table 1).
3.2. Diffusion cell studies - absorption kinetics
3.2.1. Cumulative absorption versus time for each model chemical
The cumulative absorption of model chemicals from the different
penetration enhancers changed markedly depending on the skin region
and model chemical applied. Of note, 30% v/v ethanol demonstrated a
distinct lag phase in absorption profile through all skin regions and for all
chemicals, with negligible absorption occurring in the first 30 minutes of
the experiments. The lag phase was most obvious in the benzoic acid
experiments. Following this lag phase, however, absorption rapidly
increased. This lag phase was absent for other enhancers. Discussion of
results will therefore focus on absorption following resolution of the lag
phase.
3.2.1.1. Caffeine. The addition of 1% v/v ethanol consistently showed
greater absorption compared to ARS alone for all skin regions, whereas
the relative effect of PG and 30% v/v ethanol differed depending on the
skin region (Fig. 1). In dorsal skin, the inclusion of 30% v/v ethanol
slightly reduced absorption compared to ARS alone, whereas PG reduced
absorption by approximately half.
Ventrally, absorption of caffeine was essentially unchanged for PG
compared to ARS, through both the thoracic and pelvic skin regions. In
30% v/v ethanol, caffeine absorption was similar to both ARS and PG
through thoracic skin, however the absorption profile changed in the
later sampling times in pelvic skin. Specifically, pelvic absorption of
caffeine was similar between PG, ARS and 30% v/v ethanol over the first
3 hr, however absorption rate of caffeine from 30% v/v ethanol was
lower from t ¼ 3 hr, with the final total cumulative amount absorbed
~30% lower than that from PG.
3.2.1.2. Benzoic acid. The addition of any of the investigated penetra-
tion enhancers resulted in greater absorption than in ARS alone, in all
skin regions. In contrast to caffeine, 30% v/v ethanol consistently
resulted in the most rapid uptake of benzoic acid through all skin regions.
There was also very little difference in absorption profiles between skin
regions, with 30% v/v ethanol consistently having the highest absorp-
tion, followed by PG, and then 1% v/v ethanol (Fig. 2). Notably, in dorsal
skin the improvement in absorption compared to ARS alone were similar
for PG and 1% v/v ethanol, whereas in ventral skin the difference be-
tween these enhancers was more prominent, with PG resulting in
markedly higher absorption.
3.2.1.3. Ibuprofen. The cumulative absorption versus time curves forarious penetration enhancers through dorsal, ventral thoracic and ventral pelvic
Fig. 2. Cumulative absorption versus time curves for absorption of benzoic acid for the various penetration enhancers through dorsal, ventral thoracic and ventral
pelvic Rh. marina skin. Error bars show standard error. ARS data from [17].
Fig. 3. Cumulative absorption versus time curves for absorption of ibuprofen for the various penetration enhancers through dorsal, ventral thoracic and ventral pelvic
Rh. marina skin. Error bars show standard error. ARS data from [17].
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ibuprofen from 10% and 30% v/v ethanol compared to 1% v/v ethanol,
PG and ARS (Fig. 3), with highest absorption from 30% v/v ethanol.
Absorption of ibuprofen from PG, 1% v/v ethanol, and ARS in dorsal skin
was similar.
The absorption trends in the ventral skin (both thoracic and pelvic)
were different from dorsal absorption. While absorption remained low
from both PG and 1% v/v ethanol, PG does appear to improve absorption
marginally compared to 1% v/v ethanol and ARS, especially through
thoracic skin.
Although thoracic absorption was highest for 10% and 30% v/v
ethanol, no discernible difference was noted between these enhancers. Of
interest is the observation that although the absorption characteristics of
ibuprofen from the lower ethanol concentrations and PG remain rela-
tively constant for both ventral skin regions, absorption changes signif-
icantly between these regions for the 30% v/v ethanol, with pelvic
absorption being much lower than thoracic absorption.Table 2
Flux and permeability coefficients for caffeine from a saturated solution of different pe
skin. Jss and Kp reported as mean  standard error. N ¼ 4. *indicates solvent flux valu
Solvent Dorsal Thoracic
Jss (mcg/cm2/hr) Kp (cm/hr)  103 Jss (mcg/cm2/
1% ethanol 72.747  7.632 3.781  0.793 68.939  7.67
30% ethanol 47.871  2.388* 2.547  0.254 52.286  5.29
20% PG 33.650  2.643* 1.903  0.299 69.622  6.35
53.2.2. Influence of penetration enhancers on the flux of model chemicals
1% v/v ethanol did not significantly influence flux for any of the
chemicals, and the ability of the other enhancers to significantly affect
flux was inconsistent between chemicals and skin regions.
Of interest, 30% v/v ethanol and PG produced significant reductions
in flux of caffeine (Table 2), with PG significantly reducing flux through
the dorsal skin (t ¼ –4.387, df ¼ 8, p ¼ 0.0023), and 30% v/v ethanol
reducing flux through both dorsal (t ¼ –2.909, df ¼ 8, p ¼ 0.0196) and
ventral pelvic skin (t ¼ –5.223, df ¼ 8, p¼ 0.0008). Thoracic application
of 30% v/v ethanol reduced caffeine flux substantially, however this
failed to reach significance (t ¼ –2.097, df ¼ 9, p ¼ 0.0655).
For benzoic acid and ibuprofen (Tables 3 and 4), 30% v/v ethanol
increased flux significantly for both chemicals through all skin regions.
PG had variable effects, significantly improving flux of benzoic acid
through the dorsal and thoracic skin regions and marginally improving
flux through the pelvic skin (t¼ 2.063, df¼ 10, p¼ 0.0661). Its ability to
improve flux of ibuprofen was only significant following thoracicnetration enhancers through dorsal, ventral thoracic and ventral pelvic Rh. marina
es that are significantly different (p < 0.05) to ARS flux values reported in [17].
Pelvic
hr) Kp (cm/hr)  103 Jss (mcg/cm2/hr) Kp (cm/hr)  103
0 3.584  0.797 102.391  7.108 5.322  0.739
4 2.786  0.561 40.627  4.325* 2.162  0.460
3 3.937  0.718 73.625  6.097 4.163  0.689
Table 3
Flux and permeability coefficients for benzoic acid from a saturated solution of different penetration enhancers through dorsal, ventral thoracic and ventral pelvic Rh.
marina skin. Jss and Kp reported as mean  standard error. N ¼ 4. *indicates solvent flux values that are significantly different (p < 0.05) to ARS flux values reported in
[17].
Solvent Dorsal Thoracic Pelvic
Jss (mcg/cm2/hr) Kp (cm/hr)  103 Jss (mcg/cm2/hr) Kp (cm/hr)  103 Jss (mcg/cm2/hr) Kp (cm/hr)  103
1% ethanol 17.759  2.155 4.416  0.536 11.910  2.420 2.961  0.602 19.800  2.463 4.924  0.612
30% ethanol 37.841  4.669* 3.127  0.386 33.981  5.051* 2.808  0.417 44.994  8.686* 3.718  0.718
20% PG 21.221  1.447* 9.891  0.675 17.086  0.980* 7.964  0.457 27.187  1.856 12.672  0.865
Table 4
Flux and permeability coefficients for ibuprofen from a saturated solution of different penetration enhancers through dorsal, ventral thoracic and ventral pelvic Rh.
marina skin. Jss and Kp reported as mean  standard error. N ¼ 4 except for dorsal PG where N ¼ 3. *indicates solvent flux values that are significantly different (p <
0.05) to ARS flux values reported in [17].
Solvent Dorsal Thoracic Pelvic
Jss (mcg/cm2/hr) Kp (cm/hr)  103 Jss (mcg/cm2/hr) Kp (cm/hr)  103 Jss (mcg/cm2/hr) Kp (cm/hr)  103
1% ethanol 1.406  0.061 5.791  0.501 1.303  0.142 5.365  1.167 1.504  0.071 6.196  0.582
10% ethanol 8.346  0.760* 10.306  1.876 10.841  1.832* 13.387  4.524 8.314  0.779* 10.266  1.925
30% ethanol 9.887  0.527* 7.389  0.788 9.711  1.506* 7.258  2.251 6.573  0.212* 4.913  0.316
20% PG 1.557  0.076 6.069  0.514 1.787  0.083* 6.964  0.649 1.883  0.252 7.339  1.967
V.K. Llewelyn et al. Heliyon 5 (2019) e02127application (t ¼ 2.222, df ¼ 11, p ¼ 0.0482). Finally, and interestingly,
while both 10% and 30% v/v ethanol significantly improved flux of
ibuprofen, the effect was greater for the lower (10% v/v) ethanol con-
centration, following both thoracic and pelvic application.
3.2.3. Enhancement ratio – comparing the effects of penetration enhancers
Direct comparison of the magnitude of enhancement for each pene-
tration enhancer can be made by considering the enhancement ratio (ER)
for a specified chemical and skin region (Fig. 4).
As expected from the flux and Kp data, none of the enhancers were
effective in improving the penetration of caffeine, and in some cases, a
significant reduction in caffeine penetration was observed.
The effects of ethanol were varied, and dependent upon the concen-
tration applied. 1% v/v ethanol only improved permeability for
ibuprofen, with a 2-fold increase for ventral application and 1.7-fold
increase following dorsal application. 30% v/v ethanol effectively
increased permeability of ibuprofen through all skin regions, although
the effect was lower in ventral pelvic skin compared to dorsal or thoracic
application (ER ¼ 1.5 for ventral skin, 2.16 and 2.68 for dorsal and
thoracic skin, respectively). 30% v/v ethanol was not an effective
enhancer for benzoic acid, in all cases having an ER < 1.2, nor for
caffeine (all ER < 0.75). Interestingly, 10% v/v ethanol was the most
effective enhancer for ibuprofen, with at least a 3-fold increase inFig. 4. Effect of ethanol and PG on the penetration of caffeine, benzoic acid, and ib
ARS); error bars are standard error.
6absorption (dorsal), extending to a 5-fold increase following thoracic
application.
PG generally improved absorption, except for caffeine, which did not
change appreciably following ventral application (ER¼ 1.04 and 0.90 for
thoracic and pelvic application, respectively), and was reduced by almost
50% through dorsal skin (ER ¼ 0.49). Dorsal and ventral absorption was
enhanced by PG for both benzoic acid and ibuprofen, with a 2.5- to 3.95-
fold increase for benzoic acid and 1.8- to 2.6-fold increase for ibuprofen,
depending on the skin region. Ventral applications showed the largest
increases, with ER ranging from 2.28 – 3.95.
3.3. Differential scanning calorimetry (DSC)
Three endothermic transitions were observed in fresh dorsal Rh.
marina skin samples (T2frog, T3frog, T4frog; Fig. 5) while only two transi-
tions were noted in fresh ventral skin (T2frog and T4frog; Fig. 6). The
transition temperature for T2frog was consistent between skin regions
(62.8  0.4 C), whereas the transition temperature of T4frog was higher
in dorsal skin (124.3 C versus 116.4 C). T3frog occurring at 79.7 C in
fresh dorsal skin.
Following exposure to ARS or penetration enhancers, changes in all
three transitions were noted in both dorsal and ventral skin. In dorsal
skin samples (Fig. 5), T2frog transition temperature was unaffected byuprofen. Red line indicates ER ¼ 1 (i.e., no change in penetration compared to
Fig. 5. Representative DSC thermoanalytical curves of dorsal full-thickness Rh. marina skin. From top: fresh skin; skin exposed to: ARS; 1% v/v ethanol; 10% v/v
ethanol; 30% v/v ethanol; 20% v/v PG.
Fig. 6. Representative DSC thermoanalytical curves of ventral pelvic full-thickness Rh. marina skin. From top: fresh skin; skin exposed to: ARS; 1% v/v ethanol; 10%
v/v ethanol; 30% v/v ethanol; 20% v/v PG.
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was a sequential decrease in transition temperature, with a marked dif-
ference in transition temperature, compared to fresh skin, noted for both
10% and 30% v/v ethanol (60.6 C and 60.0 C, respectively). Notably,
although the transition temperature for ARS-exposed skin did not
change, the absence of T3frog was noted, with a corresponding increase in
the enthalpy of T2frog. A similar phenomenon was observed for the 30%
v/v ethanol-exposed skin, where both T2frog and T3frog were present,
however the enthalpy of T2frog was increased with a corresponding
decrease in the enthalpy of T3frog. The opposite trend was observed for
PG; although transition temperature of T2frog was essentially unchanged,
the enthalpy of the transition decreased and an increase in T3frog
enthalpy was noted. T4frog transition temperature was essentially un-
changed for most exposed skin; the exceptions were ARS and PG-exposed
samples, which showed decreases in transition temperatures (122.6 C
for ARS, and 120.1 C for PG). Enthalpy of these transitions remained
essentially unchanged.
In ventral skin (Fig. 6), the T2frog transition temperature was unaf-
fected by ARS, however the enthalpy of the transition doubled in size7compared to fresh skin. For ethanol-exposed skin, decreases in transition
temperature were noted for all concentrations, although in contrast to
dorsal skin, 10% v/v ethanol had the lowest transition temperature
compared to fresh skin (60.3 C), followed by 30% v/v ethanol and then
1% v/v ethanol. The enthalpy of transition increased by ~50% for all
ethanol exposures. Of note, in comparison to dorsal skin where PG did
not affect transition temperature of T2frog, in ventral skin PG recorded the
greatest reduction in transition temperature, compared to fresh skin
(57.7 C). Interestingly, while T3frog was absent in fresh ventral skin, it
did appear in all PG-exposed ventral skin, but at a lower temperature
than that seen in dorsal skin (72.4 C). The effects of exposure on T4frog
were different from those observed in dorsal skin, with increases in
transition temperature and peak broadening noted for all skin exposures.
The magnitude of these temperature increases ranged from 119.4 C for
the 30% v/v ethanol concentration to 123.2 C for ARS-exposed skin. All
of the increases in transition temperature were accompanied with a
reduction in enthalpy, except for 1% v/v ethanol, which was essentially
unchanged.
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Changes suggestive of disruption to skin integrity and function were
noted for all skin samples exposed to all penetration enhancers. The most
severe changes were noticeable with ethanol exposures, with changes
observable in both epidermal and dermal skin layers. Epidermal changes,
including pale nuclei and loss of nuclear and cellular outlines, were most
obvious in dorsal skin following exposure to ethanol (Fig. 7), and the
severity of these effects increased with increasing ethanol concentra-
tions. PG-exposed skin was noted for swelling/expansion of ventral
epidermal keratinocytes resulting in a thickened epidermis (Fig. 8). None
of these effects were observed in fresh or ARS-exposed skin samples,
indicating they were not associated with the delay between sample
collection and preservation, nor with specific ARS-induced changes in
the skin.
The most obvious impact of both ethanol and PG on the skin were the
effects on the dermis, with marked separation of dermal fibrocytes by
oedematous spaces and expansion of melanocytes observed in both
dorsal and ventral skin (Fig. 9). The severity of these changes increased
with higher concentrations of ethanol, being particularly noticeable in
dorsal skin exposed to 30% v/v ethanol. In ventral skin samples, this
appeared to reach maximal effect with exposure to 10% v/v ethanol; no
further deterioration of the dermis was observed in ventral skin exposed
to 30% v/v ethanol. Skin exposed to PG showed similar separation ef-
fects, however the severity was similar to that seen following exposure to
1% v/v ethanol.
4. Discussion
4.1. Summary of key findings
While the SC provides the primary barrier to absorption in mammals,
this layer is often only 1–2 cell layers thick in frogs, contributing to the
heightened permeability of frog skin. As the SC in frogs provides only a
modest barrier to absorption, any changes to it, or other skin regions
induced by exposure to penetration enhancers is likely to significantly
impact absorption through, and regulatory function of, the skin. The DSC
and histology findings reported herein found that exposure to penetra-
tion enhancers resulted in significant changes to the skin structure,
especially in the case of ethanol. 30% v/v ethanol caused loss of cellular
outlines in the keratinised cells of the epidermis, leading to coalescence
of this layer, and severe changes to the dermis. Even 10% v/v ethanol
appeared to induce significant changes in the dermis, and so ethanol inFig. 7. Histological sections of dorsal skin in Rh. marina showing effect of ethanol ex
30% v/v ethanol for 6 hr. Note loss of cellular outlines in epidermis. Scale bar ¼ 20
8concentrations 10% v/v should be avoided, as these stark anatomical
changes may negatively affect the animal's ability to maintain physio-
logical homeostasis. A minimal effect on the skin was seen following
dorsal application of 1% v/v ethanol, however, this concentration of
ethanol was ineffective in enhancing penetration for all chemicals, so its
value in a therapeutic formulation would primarily be as a co-solvent,
enabling reduction in dosing volumes and not enhancement of absorp-
tion kinetics.
The best solvent for absorption of a hydrophilic chemical was ARS
alone, as none of the enhancers improved penetration of caffeine. 30%
v/v ethanol and PG effectively reduced caffeine absorption (30% v/v
ethanol following both dorsal and ventral application, PG only following
dorsal application). Ergo sequitur, from an environmental toxicology
perspective, hydrophilic chemicals used as overhead sprays would be
best formulated with PG to reduce absorption of these chemicals in frog
skin. Despite the reduction in absorption of hydrophilic chemicals from
both dorsal and ventral skin regions due to 30% v/v ethanol, this cannot
be recommended, as the histology results suggest that prolonged skin
contact with such formulations adversely affect the skin structure in
frogs, increasing the absorption of most other chemicals in the environ-
ment, and may also negatively affect the frog's ability to maintain
physiological homeostasis.
PG was the most consistently-effective enhancer for moderately and
highly lipophilic chemicals (all skin regions), while causing the least
observable skin changes. As the majority of therapeutic chemicals are of
moderate to high lipophilicity, PG represents the safest and most effec-
tive option for penetration enhancement for a wide range of therapeutic
chemicals in frogs.4.2. In vitro studies – absorption kinetics
As these experiments included saturated solutions of each chemical,
flux results that differ significantly from the use of ARS alone suggest
modification of the skin barrier by the penetration enhancers [20]. It is
unsurprising that higher concentrations of ethanol improved flux for
benzoic acid and ibuprofen in the current study, considering the obvious
changes in frog skin structure observed (Fig. 9). Of note is the finding that
10% v/v ethanol was more effective in improving ibuprofen flux than
30% v/v ethanol for ibuprofen. Similar results were observed in human
epidermis in a study by Watkinson et al. [21], who reported that flux of
ibuprofen from binary ethanol/water solutions increased rapidly up to a
50/50 v/v mixture, thereafter remaining relatively steady up to 75/25
v/v, before decreasing significantly in 100% ethanol. The authorsposure on epidermal structure. Left: fresh Rh. marina skin. Right: skin exposed to
mcm.
Fig. 8. Histological sections of ventral skin in Rh. marina showing effect of PG exposure on epidermal structure. Left: fresh Rh. marina skin. Right: skin exposed to 20%
v/v PG for 6 hr. Note swelling of keratinocytes compared to control. Scale bar ¼ 20 mcm.
Fig. 9. Effect of ethanol exposure on dorsal skin from Rh. marina. Ethanol concentrations increasing from left. Left-to-right: fresh skin, 1% v/v ethanol, 10% v/v
ethanol, 30% v/v ethanol. Note separation of dermal fibrocytes by oedematous spaces. Scale bar ¼ 50 mcm.
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ethanol concentrations. However, as can be seen from the histological
sections of frog skin (Fig. 7), it is likely the reduction in flux demon-
strated with the higher ethanol concentration is due to the homogeni-
zation of the SC, creating a solid, relatively lipophilic barrier to
absorption. It is likely, given the lipophilic nature of ibuprofen, that it
may partition from the dosing solution into the SC/epidermal layer,
however the epidermal restructuring caused by the ethanol may cause
ibuprofen to be less likely to partition further into the more hydrophilic
dermis. Further studies, including fixed-dose applications with full mass
balance to determine skin ibuprofen content may provide clarification of
this hypothesis. Regardless, the use of ethanol in formulations for
application to frog skin cannot be recommended at these higher con-
centrations, as such changes to the skin structure is likely to have serious
implications for the animal's ability to maintain homeostasis.
In mammalian skin studies, a lag phase for absorption is regularly
observed, as an applied chemical must diffuse from the donor, across the
thick SC and the remaining skin barrier before it reaches the receptor.
However, as frog skin is much thinner than mammalian skin, lag times
have not previously been reported when measuring transdermal ab-
sorption from simple aqueous solutions [13, 17, 22]. A lag phase was,
however, noted in the current study when chemicals were formulated in
30% ethanol. In mammals, coformulation with ethanol has different ef-
fects on the lag phase depending on the ethanol concentration, due to the
concentration-dependant effects of ethanol on the skin. Typically,
ethanol at lower concentrations causes fluidisation of the skin mem-
brane, and this is associated with decreased lag time and improved ab-
sorption. Conversely, at higher concentrations ethanol is known to
extract skin lipids; this is typically observed as a significantly increased
lag time followed by rapid flux [8, 23]. In mammals, the first mechanism9(membrane fluidisation, decreased lag time and increased permeability)
is dominant for ethanol concentrations up to ~60% [21, 24], with lag
times increasing higher ethanol concentrations. In reptiles, no lag phase
was reported in shed snake skin when an aminophylline gel was
formulated with the penetration enhancers lauric acid, sodium taur-
oglycocholate (a surfactant), or PG, however a lag time was reported
when formulated in 60% ethanol [25]. It is therefore not surprising that a
lag time was observed with the higher ethanol concentration in the
current study, but not with the lower concentrations. We predict that the
underlying mechanism is the same in both animal classes, simply that the
thinner nature of frog skin means that lower ethanol concentrations are
needed for these effects to be observed. Indeed, significant changes to the
keratinized cells of the epidermis were noted in skin samples exposed to
30% ethanol (Fig. 7).
PG was the most consistently-effective enhancer for benzoic acid and
ibuprofen, although the magnitude of improvement changed depending
on the skin region of application. It was the most effective penetration
enhancer for benzoic acid, and while not able to enhance penetration as
much as ethanol for ibuprofen solutions, induced less severe changes in
the skin, and so provides a safer alternative for penetration-
enhancement. These results contribute to the contradictory reports in
the literature as to the effectiveness of PG as a penetration enhancer on its
own [26]. In mammals, often the effect of PG on absorption kinetics is
negligible when formulated alone, with enhancement only occurring
when used in combination with another known enhancer, such as fatty
acids. It is possible that the effectiveness of PG demonstrated in the
current study is due to the thinner barrier provided by frog epidermis,
and that modulating effects of PG are insufficient to significantly alter the
barrier properties of the thicker SC in mammals. The findings in the
current study reinforce the caution required by clinicians when using
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for use in mammals in frogs, as although these formulations may be re-
ported to not influence absorption in mammals, different effects may be
observed in frogs [27].
Finally, penetration enhancers investigated in the current study had
different effects on absorption, depending on both the chemical being
applied to the skin and the skin region. As skin region influenced the
absorption kinetics from the different solvents, the application site needs
to be considered together with the formulation composition when
developing therapeutics for use in frogs. This finding is of interest, as a
previous study by this research group in Rh. marina found that the flux of
benzoic acid and ibuprofen did not significantly change between skin
regions [17] when formulated in ARS alone.
4.3. DSC and histology
This study is the first to characterise full-thickness frog skin, including
the effect of penetration enhancers, using DSC. Previous studies have
reported findings in a variety of mammalian skins (for review, see Babita
et al. [28]), and snake skin has also been reported [3]. Most studies in
mammals identify three or four main transitions common to all investi-
gated skin types (T1mammal-T4mammal), occurring at ~40 C (T1mammal;
sometimes absent in studies), 70–75 C (T2mammal), 80–85 C (T3mammal)
and 105 C (T4mammal) [28]. T2-T4 were evident in fresh dorsal frog skin,
and T2 and T4 in ventral frog skin, however T1was not observed in either
skin region. This may be due to the starting temperature in the current
experiment being necessarily high owing to the ambient laboratory
conditions, preventing observation of the transition. In addition, T2frog
and T3frog were found to be 10–15 C lower than reported in mammalian
SC, so it is possible that this first transition may also have occurred at a
reduced temperature, below the temperature range investigated in the
current study.
T2mammal and T3mammal have been attributed to intracellular lipids
changes, and lipid-protein complex changes, respectively, whereas
T4mammal is associated with protein denaturation. It is interesting that the
lipid-associated transitions in frog skin occur at lower temperatures, and
the protein denaturation at higher temperatures, than seen in mamma-
lian skin. Differences in lipid-associated transitions between species are
likely due to differences in constituent skin lipids and their arrangement
in the epidermis. In particular, lower phospholipid content of the skin has
been reported to correlate with reduced transition temperatures, and
ceramides with increased transition temperatures [28]. While the exact
lipid composition of Rh. marina skin has not been reported, the lipid
composition of epidermis in a group of frogs from Cyclorana spp. reported
0.86% phospholipid content and a complete absence of ceramides [29].
Comparatively, human SC is reported to contain 3–5% phospholipids and
27% ceramides, depending on the skin region investigated [30]. Addi-
tionally, more permeable skins typically exhibit looser packing of the
epidermal lipids and as frog skin is highly permeable, it is likely this also
contributed to the lower transition temperatures observed for T2frog and
T3frog in the current study.
An interesting finding in the current study was the observation that
for dorsal skin samples, exposure to ARS or 30% v/v ethanol resulted in a
reduction in enthalpy of T3frog with a corresponding increase in the
enthalpy of T2frog. This has been reported previously in porcine skin [31],
whereby heating of the skin resulted in a loss of T3 and an increase in the
enthalpy of T2 equivalent in size to that of T3. Of note in the current
study was the opposite finding in PG-exposed dorsal skin – where T3frog
increased in enthalpy, with a corresponding decrease in enthalpy of
T2frog. Studies utilizing different methodologies to investigate changes in
frog skin following PG-exposure will assist in explaining this
phenomenon.
T4mammal, in contrast, is associatedwith the hydration status of skin; it
is absent in dehydrated skin and skin with a total water content of<15%,
and the temperature of this transition declines continuously with
increasing hydration of the skin [28]. Further, it has been suggested that10higher transition temperatures of T4mammal with broad peaks indicates
dehydration of the membrane. As the pelvic ventral patch in frogs is
physiologically designed to optimize water uptake, it is perhaps unsur-
prising that the transition temperature was lower for fresh ventral skin
samples than for the dorsal samples. Similarly, this may also explain the
reduction in T4frog temperature following exposure of dorsal skin to ARS
(which would be expected to increase hydration of the skin), and the
increases in T4frog with accompanying broadening of the peak, for all
ventral skin exposures, as presumably fresh ventral skin would already be
optimally-hydrated.
For penetration enhancer-exposed skin samples, the thermal analysis
curves for dorsal skin exposed to ARS or 1% v/v ethanol were essentially
the same, corresponding with the in vitro absorption studies and histol-
ogy, which suggested that 1% v/v ethanol only marginally affects skin
structure and absorption kinetics. Of note, considering the in vitro ab-
sorption results for PG in the current study, is the DSC and histology
results for PG-exposed skin samples, which showed a reduction in tran-
sition temperature for T2frog in both dorsal and ventral skin. These
findings concur with those of Brinkmann and Müller-Goymann [9], who
found a similar reduction in transition temperature for T2 when inves-
tigating the impact of PG pretreatment on human skin. Following x-ray
diffraction studies on the pre-exposed skin, the authors concluded that
PG integrates into the hydrophilic regions of the SC lipid bilayer, causing
expansion to this region and thus disturbing the lipid organization. This
conclusion also agrees with the histology findings in the current study,
which showed distinct swelling of the epidermal layers of the frog skin
following PG exposure.
An ideal chemical penetration enhancer should enhance penetration,
without permanently disrupting the skin structure. However, the histol-
ogy results for ethanol demonstrated significant changes in both the
epidermal and dermal skin layers. At higher concentrations, ethanol is
reported to extract lipids from the SC in mammals [8]; in the current
study higher ethanol concentrations altered the cellular outlines of the
epidermal keratinocytes, causing coalescence of the keratinocytes. These
effects have numerous safety implications: lipid extraction can create
pores in the SC, allowing unimpeded passage of chemicals into the
dermis and supratherapeutic (and potentially toxic) drug levels, whereas
disruption of the keratinocyte outlines and coalescence of the keratino-
cytes may result in the formation of a relatively impervious barrier,
which may either impede drug absorption (resulting in sub-therapeutic
effects) or could provide a depot for sustained drug release. Such dam-
age to the skin is irreversible and would remain until new epidermal
turnover is complete. Additionally, such skin damage in a frog would be
likely to substantially impact on the ability of the frog to maintain
physiological homeostasis, leading to impaired fluid and electrolyte
balance. While skin changes, including expansion of the epidermal ker-
atinocytes, were noted in PG-exposed skin, these changes are likely to be
more readily reversible than those identified in ethanol-exposed skin.
4.4. General discussion
While the focus of this study has been on the impact of penetration
enhancers on model chemical absorption, the ability of the enhancers
themselves to be absorbed must be considered. Ethanol and PG rapidly
penetrate mammalian skin; indeed, the initial rapid increase in absorp-
tion noted with benzoic acid and ibuprofen when formulated in ethanol
in the current study is likely due to initial solvent drag. These results
emphasise the need for the clinician and the environmental toxicologist
to consider the impact formulation of chemical(s) with penetration en-
hancers may have on systemic absorption of the chemical, while also
considering that the enhancers themselves are also likely to be absorbed,
having local or systemic effects including potential toxicity. Krause et al.
[32] reported on toxicity resulting in death of a group of red-eyed tree
frogs (Agalychnis calidryas) following topical application of ivermectin
diluted in PG. Necropsy results showed supra-therapeutic levels of both
the ivermectin and PG, and the authors concluded that toxicity was likely
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molecule with a logP (estimated) of 5.83 [33]. In the current study,
ibuprofen, the most lipophilic chemical investigated, showed a
1.8–2.6-fold increase in penetration following formulation in 20% v/v
PG. It is therefore likely that the penetration-enhancing effects of the PG
contributed to the toxicity reported by Krause et al. [32]. Similarly,
toxicology researchers have highlighted that the inclusion of surfactants
in the herbicide glyphosate contributes to the toxicity of these formula-
tions to amphibians [34]. Howe et al. [35] investigated individually the
toxicity of neat glyphosate, the surfactant used in some glyphosate for-
mulations, and five commercial glyphosate formulations in four frog
species. Acute toxicity was highest with the surfactant alone, and lowest
with the neat glyphosate. However, this and other studies have been
primarily concerned with the toxicity caused by the surfactant itself, and
have not considered that the surfactant is also likely increasing the ab-
sorption of the glyphosate in the formulation, contributing to the toxi-
cological profile. While the current study did not investigate surfactant
action on percutaneous absorption in frogs, surfactants are known
penetration-enhancers and should be expected to influence absorption of
both the chemical and the enhancer itself. Thus, both the contribution of
penetration enhancers to altered absorption and the individual toxicity of
the enhancers themselves must be considered when formulating chem-
icals which may be administered to frogs (whether intentionally, for
therapeutic purposes, or inadvertently following exposure in their
habitat). Studies that investigate other penetration enhancers that are
commonly included in agricultural and industrial chemical formulations
would therefore provide valuable data regarding risk assessment and
management when using these products in frog habitats.
5. Conclusions
The penetration enhancers investigated in this study are the most
common agents used in commercial and compounded therapeutic
liquid formulations administered to frogs, and are also often included
in agrichemicals and other industrial products and so are likely to be
present in frog habitats. The results herein provide information on the
absorption-enhancing effects of these agents when included in formu-
lations, and can be used to guide dose/application site adjustment
when used in frogs. In particular, the use of ethanol in concentrations
over 10% v/v cannot be recommended, despite demonstrated
penetration-enhancing effects, owing to the severe skin changes caused
by ethanol at these concentrations. 1% v/v ethanol may find use in
formulations as a co-solvent, with minimal impact on both absorption
kinetics and skin morphology. PG can enhance percutaneous absorption
of moderately and highly-lipophilic chemicals, with minimal impact on
the skin, and so should be considered when penetration enhancement
of these chemicals through frog skin is required. Finally, hydrophilic
chemicals may have significantly reduced absorption when included in
formulations containing PG or higher concentrations of ethanol,
particularly when administered to the ventral skin surface, and so these
enhancers should be avoided unless reduced absorption is desired, for
example in retarding absorption of hydrophilic environmental
contaminants.
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